Skip to main content
    C

    Curis Inc (CRIS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.54
    +0.11 (+24.32%)

    Market Cap: $2.91M

    Last updated: Nov 17, 2026 at 4:42 PM ET

    Curis Inc (CRIS) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Curis (CRIS) has a market cap of $2.91M. It kept -1893.15% of revenue as net income over the last 12 months. It holds $5.01M more cash than debt, 172.26% of its market cap.

    Total Valuation

    Market Cap$2.91M
    Latest price (Nov 17, 2026)$0.54

    Key Dates

    The next earnings report is expected on Mar 17, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 17, 2027 (expected)
    Last Earnings DateNov 12, 2026
    Fiscal Year EndDecember

    Valuation Ratios

    Sales and book value multiples are 2.0x and 0.9x. Its year-end P/S ranged from 1.3x to 112.8x from 2016 to 2025.

    P/S Ratio2.0x
    Forward P/S11.6x
    P/B Ratio0.9x

    Valuation history and multiples

    Price Statistics

    The stock is down 97.96% over 52 weeks and trades 26.03% below its 50-day average.

    Beta (1Y)2.03
    52-Week Change-97.96%
    1-Month Change+41.98%
    3-Month Change-68.50%
    6-Month Change-94.31%
    5-Year Change-99.98%
    10-Year Change-99.99%
    Total Return (1Y)-97.96%
    Total Return (3Y CAGR)-84.55%
    Total Return (5Y CAGR)-80.86%
    Max Drawdown (1Y)-98.62%
    Max Drawdown (3Y)-99.89%
    Sharpe Ratio (1Y)-2.58
    Correlation with SPY (1Y)0.19
    50-Day Average$0.73
    200-Day Average$7.97
    52-Week Range$0.33 to $28.40
    RSI (14 Days)44.2
    Average Volume (20 Days)12.43M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 0.43x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio0.43x
    Quick Ratio0.43x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -844.53% and return on assets is -114.60% over the last 12 months.

    Return on Equity (ROE)-844.53%
    Return on Assets (ROA)-114.60%
    Return on Capital Employed (ROCE)-840.77%
    ROA (5Y Average)-56.91%
    Asset Turnover0.05x

    Scores

    CRIS has an Altman Z-Score of -100.16, in the distress zone below 1.81, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Altman Z-Score-100.16
    Altman Z ZoneDistress
    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue of $1.14M over the last 12 months is down 90.23% from the 12 months before.

    Revenue$1.14M
    Revenue Growth (YoY)-90.23%
    Gross Profit$1.14M
    Operating Income-$10.59M
    Pretax Income-$21.54M
    Net Income-$21.54M
    EBIT-$21.45M
    Reported EPS (TTM)-$40.91

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 13.56% of the $18.80M in total assets.

    Cash and Equivalents$5.01M
    Total Debt$0
    Net Cash$5.01M
    Net Cash Per Share$1.20
    Working Capital-$9.33M
    Shareholder Equity$2.55M
    Book Value Per Share$0.61
    Tangible Book Value-$6.43M
    Total Assets$18.80M
    Total Liabilities$16.25M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$30.77M
    FCF Per Share-$4.61
    Depreciation and Amortization$62.00K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -930.40%.

    Gross Margin100.00%
    Operating Margin-930.40%
    Pretax Margin-1893.15%
    Net Margin-1893.15%
    EBIT Margin-1884.71%

    Growth

    Revenue fell 2.42% a year over 3 years.

    Revenue Growth (3Y CAGR)-2.42%
    Revenue Growth (5Y CAGR)-2.71%

    Revenue and profit by year

    Dividends and Yields

    CRIS does not pay a dividend.

    Buyback Yield-1070.23%
    Shareholder Yield-1070.23%

    Stock Splits

    The last split was a 1-for-20 reverse split on Jul 6, 2026.

    Last Split DateJul 6, 2026
    Split TypeReverse split
    Split Ratio1:20

    Analyst Forecast

    Consensus estimates put revenue growth at 4.61% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+4.61%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About CRIS

    What is CRIS's market cap?

    Curis has a market cap of $2.91M.

    How many shares of CRIS are outstanding?

    Curis has 4.18M shares outstanding.

    Does CRIS pay a dividend?

    No. Curis does not pay a dividend.

    How much debt does CRIS have?

    Curis has $0 of total debt and $5.01M of cash and equivalents, a net cash position of $5.01M.